Senior US Economist, Capital Economics
Senior US Economist at Toronto, Canada-based Capital Economics, which analyzes the American economy for foreign investors and large banks
PROFILE
Paul Ashworth
Guest
FROM Paul Ashworth
To the Point
Drop in Gross Domestic Product Could Have Been Worse The US economy shrank last year, but not as fast as expected. Instead of a predicted drop of 5.1 percent, it was only 3.8. That's hardly good news. Paul Ashworth, who analyzes the US economy for foreign investors and large banks, is senior US economist at Capital Economics in Toronto.
Recommended
To the Point
Trump plays scolder-in-chief with NATO allies At the opening of NATO’s dramatic new headquarters in Brussels today, President Trump acknowledged that Article 5 — promising that “an attack on one nation is an attack on all” -- has only been invoked one time: in the aftermath of September 11. But the President failed to provide what 27 other Alliance members have been waiting for: a re-commitment by America’s new leader to Article 5. Instead, they got a scolding.
To the Point
Ex-FBI Director Comey tells his side of the story Today, former FBI Director James Comey came close to calling the President who fired him a liar. The White House denied the claim and called it insulting, but Republican Senators did not challenge Comey’s truthfulness. Many questions remain: did the President try to obstruct a federal investigation? Later, we’ll go behind the “velvet rope” for a look at 5-Star health care for the richest Americans.
To the Point
Replacing Obamacare: Now you see it… now you don’t As the Senate deliberates replacing Obmacare, health coverage for millions of people is at stake. There've been no public hearings, and a draft measure won't be made public. Is the House version so unpopular that that Senate is hiding a version that looks much the same?
To the Point
Who's to blame for the opioid crisis? Some of the lawyers who took on Big Tobacco are now going after Big Pharma. It’s all about the deadly epidemic of opioid use. Are the drug companies to blame? What about the users? Later, on today’s Talking Point: making sense of Britain’s upset election.